JUDGING BENEFITS AND HARMS OF MEDICINES
Put more trust in the trustworthy and less in the untrustworthy to improve judgement of medicines
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The Academy of Medical Sciences recommends involving patients, carers, and the public in research as a means of tackling concerns about the erosion of public trust, overmedication, and conflicts of interest.
1 Patient and public involvement, however, is already an imperative for much publicly funded UK health research and has been for some time. Moreover, the field of involvement is not outside of or immune to conflicts of interest or the erosion of trust, especially given that such involvement is often reduced to time consuming and tokenistic box ticking exercises.
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Following O'Neill, 3 we should aim for more trust in the trustworthy and less in the untrustworthy, not for more trust across the board. This requires building, and in some cases rebuilding, trustworthiness in health research and its processes and practices of involvement. Pervasive discussion of the "deficit model," which implies that all public and professional scepticism of science is unfounded and that corrective communication by experts is necessary, is unhelpful. We need to encourage broader debate that attends to those concerns. 4 Competing interests: None declared. 
